Biotechnology Still Struggling To Gain A Public Awareness Foothold

The industry's supporters and critics both claim that surveys support their causes; meanwhile, its boosters ponder improvements to their educational efforts. POLL POSITION: Ronnie Cummins claims that the Pure Food Campaign's surveys reveal negative attitudes toward biotech. Biotechnology representatives paint a rosy picture of the industry's future, portraying it as a rising star gaining influence among commercial interests and policymakers. But surveys reveal a wide range of public reaction

Written byThomas Durso
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share


The industry's supporters and critics both claim that surveys support their causes; meanwhile, its boosters ponder improvements to their educational efforts.

POLL POSITION: Ronnie Cummins claims that the Pure Food Campaign's surveys reveal negative attitudes toward biotech.
Biotechnology representatives paint a rosy picture of the industry's future, portraying it as a rising star gaining influence among commercial interests and policymakers. But surveys reveal a wide range of public reactions and illustrate that people are far more accepting of some forms of biotechnology, such as those applied medically, than of others, such as those used in agricultural applications.

In addition, a vocal anti-biotechnology contingent continues to make its presence felt. Anti-biotech activists argue that people are skeptical of the industry's claims of better products and adequate safety measures, and claim that in light of this skepticism, negative images are justified. Observers say that with many biotech companies still struggling to attract ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies